Patient characteristics of 150 patients with DLBCL before ICE chemotherapy
Characteristic . | No. . | % . |
---|---|---|
Disease status | ||
Primary refractory | 67 | 45 |
Relapsed | 83 | 55 |
Sex | ||
Male | 96 | 64 |
Female | 54 | 36 |
Age, y | ||
Median | 49 | |
Range | 16-86 | |
Age stratified | ||
Younger than 60 y | 125 | 83 |
60 y or older | 25 | 17 |
KPS | ||
80% or more | 84 | 56 |
Less than 80% | 66 | 44 |
LDH | ||
Normal | 63 | 42 |
Below normal | 87 | 58 |
ENS | ||
One site or less | 84 | 56 |
More than 1 site | 66 | 44 |
Stage | ||
I/II | 33 | 22 |
III/IV | 17 | 78 |
Bone marrow | ||
Uninvolved | 117 | 78 |
Involved | 33 | 22 |
sAAIPI | ||
Low | 20 | 13 |
Low-intermediate | 40 | 27 |
High-intermediate | 55 | 37 |
High | 35 | 23 |
Characteristic . | No. . | % . |
---|---|---|
Disease status | ||
Primary refractory | 67 | 45 |
Relapsed | 83 | 55 |
Sex | ||
Male | 96 | 64 |
Female | 54 | 36 |
Age, y | ||
Median | 49 | |
Range | 16-86 | |
Age stratified | ||
Younger than 60 y | 125 | 83 |
60 y or older | 25 | 17 |
KPS | ||
80% or more | 84 | 56 |
Less than 80% | 66 | 44 |
LDH | ||
Normal | 63 | 42 |
Below normal | 87 | 58 |
ENS | ||
One site or less | 84 | 56 |
More than 1 site | 66 | 44 |
Stage | ||
I/II | 33 | 22 |
III/IV | 17 | 78 |
Bone marrow | ||
Uninvolved | 117 | 78 |
Involved | 33 | 22 |
sAAIPI | ||
Low | 20 | 13 |
Low-intermediate | 40 | 27 |
High-intermediate | 55 | 37 |
High | 35 | 23 |
Response to ICE-based second-line chemotherapy: